2021
DOI: 10.1101/2021.12.19.21268069
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Mutational analysis of SARS-CoV-2. ORF8 and the evolution of the Delta and Omicron variants

Abstract: SARS-CoV-2 the virus responsible for the current pandemic. This virus is continually evolving, adapting to both innate and acquired immune responses and therapeutic drugs. Therefore, it is important to understand how the virus evolving to design the appropriate therapeutic and vaccine in preparation for future variants. Here, we used the online SARS-CoV-2 databases, Nextstrain and Ourworld, to map the evolution and epidemiology of the virus. We identified 30 high entropy residues which underwent a progressive … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…Recently, in a study of mutational changes in SARS-CoV-2, it was reported that a fraction of the Omicron variant acquired a mutation in the ORF8 encoding region ( 24 ). Because ORF8 is associated with immune evasion and pathogenicity, further studies to investigate the characteristics of this protein within the omicron variant are important.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, in a study of mutational changes in SARS-CoV-2, it was reported that a fraction of the Omicron variant acquired a mutation in the ORF8 encoding region ( 24 ). Because ORF8 is associated with immune evasion and pathogenicity, further studies to investigate the characteristics of this protein within the omicron variant are important.…”
Section: Discussionmentioning
confidence: 99%
“…On average, in 2020, more than 15 thousand women were diagnosed with new breast cancer and more than 6000 death cases were recorded [2]. In addition, most women with breast cancer are examined and detected at a late stage, so the prognosis is often very severe and the burden of treatment costs can be 40-50 times higher than the average family income [3]. Meanwhile, breast cancer is a completely curable cancer if it is detected early and treated promptly [4], and the cost of treatment in the early stage accounts for only 20% of that of treatment in the late stage [5].…”
Section: Introductionmentioning
confidence: 99%